Pulse Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Pulse Biosciences.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for PLSE.

Recommendation Trends

Rating	Apr '22	May '22	Jun '22	Jul '22	Aug '22
Strong Buy	1	0	0	0	0
Buy	1	1	1	1	1
Hold	0	1	1	1	1
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 21, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 13, 2022
Chris Cooley Stephens & Co.	Stephens & Co.	Buy Maintains $14 → $12	Buy	Maintains	$14 → $12	-32.05%	Apr 1, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $20 → $8.5	Strong Buy	Maintains	$20 → $8.5	-51.87%	Apr 1, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $43 → $20	Strong Buy	Maintains	$43 → $20	+13.25%	Feb 10, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.92

from -0.88

EPS Next Year

n/a

from -0.92

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	-	-	1.42M	700.00K	-	-
Revenue Growth	-	-	-	-50.63%	-	-
EPS	-2.26	-2.14	-2.28	-1.72	-0.88	-0.92
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2024
High	-
Avg	-
Low	-

EPS Forecast

EPS	2024
High	-0.95
Avg	-0.92
Low	-0.88

EPS Growth

EPS Growth	2024
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.